Favorable prognostic impact of phosphatase and tensin homolog alterations in wild-type isocitrate dehydrogenase and telomerase reverse transcriptase promoter glioblastoma.
Higa N, Akahane T, Yokoyama S, Makino R, Yonezawa H, Uchida H, Takajo T, Kirishima M, Hamada T, Noguchi N, Otsuji R, Kuga D, Nagasaka S, Yamahata H, Yamamoto J, Yoshimoto K, Tanimoto A, Hanaya R.
Higa N, et al. Among authors: nagasaka s.
Neurooncol Adv. 2023 Jun 28;5(1):vdad078. doi: 10.1093/noajnl/vdad078. eCollection 2023 Jan-Dec.
Neurooncol Adv. 2023.
PMID: 37528810
Free PMC article.